Which State Is Ranked #1 For Lithium Investors?
The Fraser Institute ran a survey to find the best spot in the world for lithium mining. They researched 77 spots from around the world… and the Nevada Desert won the #1 spot by a landslide. And this small mining company just staked 11,700 acres of mineral claims in Nevada's hottest lithium spot...
See Why This Lithium Stock Could Explode

ARMP Insider Trading (Armata Pharmaceuticals)

Insider Ownership Percentage: 75.80%
Insider Buying (Last 12 Months): $13,929,288.75
Insider Selling (Last 12 Months): $0.00

Armata Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Armata Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Armata Pharmaceuticals Share Price & Price History

Current Price: $4.50
Price Change: Price Decrease of -0.41 (-8.35%)
As of 12/3/2021 01:00 AM ET

This chart shows the closing price history over time for ARMP up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
US Economy Faces New $1.4 Trillion Threat
Almost every electronic manufacturer depends on this one resource. And it's running dangerously low. It's not lithium. It's not gold. It's not hydrogen. But this new industry could be one of the best opportunities for investors in 2021.
See Why Tech Giants Are Hoarding This Resource

Armata Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/17/2021Innoviva, Inc.DirectorBuy4,285,935$3.25$13,929,288.75
3/27/2020Innoviva, Inc.Major ShareholderBuy7,717,661$3.10$23,924,749.10
See Full Table
Insider Buying at Armata Pharmaceuticals?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Armata Pharmaceuticals and related companies.

SEC Filings (Institutional Ownership Changes) for Armata Pharmaceuticals (NYSEAMERICAN:ARMP)

4.64% of Armata Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at ARMP by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Armata Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/12/2021Renaissance Technologies LLC106,092$0.38M0.0%-9.1%0.425%Search for SEC Filing on Google Icon
11/9/2021BlackRock Inc.20,571$74K0.0%+928.0%0.082%Search for SEC Filing on Google Icon
11/8/2021Synovus Financial Corp48,060$0.17M0.0%+108.4%0.193%Search for SEC Filing on Google Icon
8/17/2021Millennium Management LLC10,055$40K0.0%-34.7%0.040%Search for SEC Filing on Google Icon
8/17/2021Citadel Advisors LLC10,873$43K0.0%-49.0%0.044%Search for SEC Filing on Google Icon
8/17/2021Bridgeway Capital Management LLC113,400$0.45M0.0%+134.3%0.455%Search for SEC Filing on Google Icon
8/13/2021Renaissance Technologies LLC116,696$0.46M0.0%-5.8%0.468%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.167,378$0.67M0.0%+121.4%0.671%Search for SEC Filing on Google Icon
5/21/2021Citadel Advisors LLC21,306$0.10M0.0%N/A0.085%Search for SEC Filing on Google Icon
5/18/2021Millennium Management LLC15,401$74K0.0%N/A0.062%Search for SEC Filing on Google Icon
5/18/2021Loomis Sayles & Co. L P129,956$0.62M0.0%N/A0.521%Search for SEC Filing on Google Icon
5/18/2021Citadel Advisors LLC21,306$0.10M0.0%N/A0.085%Search for SEC Filing on Google Icon
5/13/2021Renaissance Technologies LLC123,816$0.59M0.0%+25.1%0.496%Search for SEC Filing on Google Icon
5/13/2021Edgewood Management LLC50,000$0.24M0.0%+25.0%0.200%Search for SEC Filing on Google Icon
5/12/2021Geode Capital Management LLC10,188$48K0.0%N/A0.041%Search for SEC Filing on Google Icon
5/12/2021UBS Group AG6,017$29K0.0%+73.4%0.024%Search for SEC Filing on Google Icon
5/7/2021BlackRock Inc.40,448$0.19M0.0%+12.4%0.162%Search for SEC Filing on Google Icon
2/10/2021Renaissance Technologies LLC98,996$0.30M0.0%+5.7%0.529%Search for SEC Filing on Google Icon
2/5/2021BlackRock Inc.35,982$0.11M0.0%-12.1%0.192%Search for SEC Filing on Google Icon
10/20/2020Wedbush Securities Inc.10,103$32K0.0%N/A0.054%Search for SEC Filing on Google Icon
8/14/2020Bank of America Corp DE633,944$2.49M0.0%+20,583.3%5.802%Search for SEC Filing on Google Icon
5/13/2020Edgewood Management LLC40,000$0.12M0.0%+100.0%0.366%Search for SEC Filing on Google Icon
5/13/2020SeaCrest Wealth Management LLC12,655$39K0.0%N/A0.116%Search for SEC Filing on Google Icon
2/14/2020Edgewood Management LLC20,000$65K0.0%N/A0.201%Search for SEC Filing on Google Icon
11/27/2019Stifel Financial Corp22,599$84K0.0%N/A0.227%Search for SEC Filing on Google Icon
8/14/2019Vanguard Group Inc.15,151$61K0.0%N/A0.634%Search for SEC Filing on Google Icon
8/13/2019BlackRock Inc.11,264$45K0.0%N/A0.471%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Armata Pharmaceuticals logo
Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, which focuses on the development of bacteriophage therapeutics for the treatment of drug-resistant bacterial infections. The company was founded on May 9, 2019 and is headquartered in Los Angeles, CA.
Read More on Armata Pharmaceuticals

Today's Range

Now: $4.50
Low: $4.50
High: $4.83

50 Day Range

MA: N/A

52 Week Range

Now: $4.50
Low: $2.56
High: $10.48

Volume

13,983 shs

Average Volume

28,521 shs

Market Capitalization

$121.89 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.15

Who are the company insiders with the largest holdings of Armata Pharmaceuticals?

Armata Pharmaceuticals' top insider investors include:
  1. Innoviva, Inc (Director)
  2. Innoviva, Inc (Major Shareholder)

Who are the major institutional investors of Armata Pharmaceuticals?

Armata Pharmaceuticals' top institutional investors include:
  1. Renaissance Technologies LLC — 0.43%
  2. Synovus Financial Corp — 0.19%
  3. BlackRock Inc. — 0.08%

Which major investors are selling Armata Pharmaceuticals stock?

In the previous quarter, ARMP stock was sold by these institutional investors:
  1. Renaissance Technologies LLC

Which major investors are buying Armata Pharmaceuticals stock?

During the last quarter, ARMP stock was bought by institutional investors including:
  1. Synovus Financial Corp
  2. BlackRock Inc.
During the previous year, these company insiders have bought Armata Pharmaceuticals stock:
  1. Innoviva, Inc (Director)
  2. Innoviva, Inc (Major Shareholder)
Investor Alert: Argentina Loaded With "White Gold" Opportunity
Experts expect the global lithium market to grow by 500% due to the explosion of electric vehicles and green energy. And one small-cap company just snagged a large lithium deposit in a renowned South American location.
Read about this once-in-a-lifetime opportunity